InvestorsHub Logo
Followers 43
Posts 5432
Boards Moderated 0
Alias Born 11/15/2013

Re: runninggirl2016 post# 391658

Tuesday, 07/26/2022 6:27:19 PM

Tuesday, July 26, 2022 6:27:19 PM

Post# of 403061
Good stuff runninggirl. Your quote "potential partners" certainly spells it out and likely a key reason for the payer analysis. With it they now know payers would support Brilacidin's commercialization.

This from the last PR- “This analysis reinforces Brilacidin’s potential to become a breakthrough OM treatment and commercialization success,”

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News